BRGX Stock Overview
Operates a social media content management platform. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BioRegenx, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0092 |
| 52 Week High | US$0.085 |
| 52 Week Low | US$0.009 |
| Beta | 0 |
| 1 Month Change | -33.09% |
| 3 Month Change | -38.33% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -84.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| BRGX | US Interactive Media and Services | US Market | |
|---|---|---|---|
| 7D | -28.8% | 0.6% | -2.1% |
| 1Y | n/a | 41.8% | 21.3% |
Return vs Industry: Insufficient data to determine how BRGX performed against the US Interactive Media and Services industry.
Return vs Market: Insufficient data to determine how BRGX performed against the US Market.
Price Volatility
| BRGX volatility | |
|---|---|
| BRGX Average Weekly Movement | 41.3% |
| Interactive Media and Services Industry Average Movement | 8.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: BRGX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BRGX's weekly volatility has decreased from 53% to 41% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 10 | William Resides | www.findit.com |
BioRegenx, Inc. operates a social media content management platform. Its platform provides an interactive search engine for all content posted in Findit to appear in Findit search, as well as allows members the ability to post, share, and manage their content. The company also offers online tools through Findit.com and Findit app, such as Claim Your Name, Search Engine Optimization, content and social media campaigns, and web design services.
BioRegenx, Inc. Fundamentals Summary
| BRGX fundamental statistics | |
|---|---|
| Market cap | US$8.85m |
| Earnings (TTM) | -US$1.88m |
| Revenue (TTM) | n/a |
-10.6x
P/S Ratio-4.7x
P/E RatioIs BRGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRGX income statement (TTM) | |
|---|---|
| Revenue | -US$831.55k |
| Cost of Revenue | -US$155.68k |
| Gross Profit | -US$675.87k |
| Other Expenses | US$1.21m |
| Earnings | -US$1.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.002 |
| Gross Margin | 81.28% |
| Net Profit Margin | 226.24% |
| Debt/Equity Ratio | 15.9% |
How did BRGX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/11 18:05 |
| End of Day Share Price | 2025/01/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioRegenx, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|